أخبار السوق

تابع أحدث الأخبار المالية والاقتصادية وتحديثات الأسواق والتقارير والتحليلات على PipVero.

المصدر: GlobeNewsWire وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
AZIO AI Secures Sales Pipeline for 128 NVIDIA HGX B300 Systems

AZIO AI Secures Sales Pipeline for 128 NVIDIA HGX B300 Systems

Initial agreement contemplates the purchase of up to 128 NVIDIA HGX B300 AI systems with an estimated aggregate hardware value of approximately $77 million based on current market pricing, subject to future purchase orders and customary conditions

الرموز ذات الصلة 1
المصدر: GlobeNewsWire
زيارة المصدر
تعليق
المصدر: PYMNTS وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
ThredUp Navigates K-Shaped Economy as Revenues Climb 17%

ThredUp Navigates K-Shaped Economy as Revenues Climb 17%

Online secondhand marketplace ThredUp is adjusting its marketing tactics while navigating a “K-shaped” economy. The company reported quarterly earnings Wednesday (Aug. 5) showing revenues of $90.8 million, up 17% from the same quarter last year.

الرموز ذات الصلة 1
TDUP TDUP
المصدر: PYMNTS
زيارة المصدر
تعليق
المصدر: WSJ وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
U.K. Waves Through $81 Billion Paramount-Warner Bros. Deal

U.K. Waves Through $81 Billion Paramount-Warner Bros. Deal

The deal still faces substantial legal challenges in the U.S., where state attorneys general have sued to block the purchase.

الرموز ذات الصلة 1
PGRE PGRE
المصدر: WSJ
زيارة المصدر
تعليق
المصدر: GlobeNewsWire وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates

MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and immune disorders, today announced that it will report financial results for the second quarter ended June 30, 2026, before the market opens on Thursday, August 13, 2026. The Company will host a conference call and webcast at 8:30 AM ET that morning to review financial results and provide a corporate update focused on the clinical advancement of agenT-797, MiNK's off-the-shelf allogeneic iNKT cell therapy, in acute lung injury.

الرموز ذات الصلة 1
INKT INKT
المصدر: GlobeNewsWire
زيارة المصدر
تعليق
المصدر: Proactive Investors وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Nasdaq heading lower on earnings falls for AppLovin, Western Digital and SanDisk

Nasdaq heading lower on earnings falls for AppLovin, Western Digital and SanDisk

Wall Street was predicted to see a mixed open on Thursday, as another batch of technology earnings undermines confidence and apparent progress towards an Iran deal raises fears of yet another false dawn. Dow Jones futures were up 57 points, or 0.1%, with the blue-chip index on course to build on the previous session's record close.

الرموز ذات الصلة 1
NDAQ NDAQ
المصدر: Proactive Investors
زيارة المصدر
تعليق
المصدر: Newsfile Corp وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Kaplan Fox Advises Investors of Alignment Healthcare, Inc. (ALHC) to Contact the Firm Regarding a Securities Investigation

Kaplan Fox Advises Investors of Alignment Healthcare, Inc. (ALHC) to Contact the Firm Regarding a Securities Investigation

New York, New York--(Newsfile Corp. - August 6, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ: ALHC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may CLICK HERE to contact us.

الرموز ذات الصلة 1
ALHC ALHC
المصدر: Newsfile Corp
زيارة المصدر
تعليق
المصدر: Business Wire وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Coincheck Reports Financial Results for First Quarter of Year Ending March 31, 2027

Coincheck Reports Financial Results for First Quarter of Year Ending March 31, 2027

AMSTERDAM--(BUSINESS WIRE)--Coincheck Group N.V. (NASDAQ: CNCK) (“Coincheck Group” or the “Company”), a Dutch public limited liability company that provides digital asset trade execution, custody, staking and asset management services, today reported financial results for the first quarter of the fiscal year ending March 31, 2027 (“fiscal 2027”). References to “fiscal 2026” mean the fiscal year ended March 31, 2026. Financial Highlights:1 Certain Year-Over-Year Highlights Total revenue for the.

الرموز ذات الصلة 1
CNCK CNCK
المصدر: Business Wire
زيارة المصدر
تعليق
المصدر: CNBC وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Warner Bros. Discovery reports 10% jump in streaming revenue ahead of proposed Paramount combination

Warner Bros. Discovery reports 10% jump in streaming revenue ahead of proposed Paramount combination

Warner Bros. Discovery reported strong revenue growth with HBO Max in its second-quarter earnings Thursday.

الرموز ذات الصلة 1
PGRE PGRE
المصدر: CNBC
زيارة المصدر
تعليق
المصدر: Seeking Alpha وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
MPLX Q2: A Soft-Looking Quarter That Quietly De-Risked The Thesis

MPLX Q2: A Soft-Looking Quarter That Quietly De-Risked The Thesis

MPLX (MPLX) remains a Strong Buy, with reliable income and visible growth supported by robust project execution and strong demand. Distribution coverage remains healthy at ~1.3x, with a 12.5% distribution growth commitment now extended through 2026 and 2027. Recent distributable cash flow softness is attributed to timing and financing of growth projects, not structural weakness, with leverage at a manageable ~3.7x.

الرموز ذات الصلة 1
MPLX MPLX
المصدر: Seeking Alpha
زيارة المصدر
تعليق
المصدر: Seeking Alpha وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Travere Therapeutics Q2 Earnings: Why I'm Downgrading To Hold (Again)

Travere Therapeutics Q2 Earnings: Why I'm Downgrading To Hold (Again)

Travere Therapeutics is downgraded from Buy to Hold after a >130% rally, reflecting competitive risks and valuation concerns. Filspari's Q2 net sales surged 96% YoY to $141M, but $3B+ peak sales guidance faces new competition in IgAN and FSGS markets. TVTX's pipeline expansion with civorebrutinib and pegtibatinase targets rare kidney and metabolic diseases, but both remain early-stage with uncertain timelines.

الرموز ذات الصلة 1
TVTX TVTX
المصدر: Seeking Alpha
زيارة المصدر
تعليق
المصدر: PRNewsWire وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
NetEase Cloud Music Inc. to Report First Half 2026 Financial Results on August 20, 2026

NetEase Cloud Music Inc. to Report First Half 2026 Financial Results on August 20, 2026

HANGZHOU, China, Aug. 6, 2026 /PRNewswire/ -- NetEase Cloud Music Inc. (HKEX: 9899 or the "Company"), a leading interactive music streaming service provider in China, today announced that it will report its financial results for the first half year of 2026 ended June 30, 2026 on Thursday, August 20, 2026, after the Hong Kong market closes. The Company's management will host an earnings conference call at 7:00 p.m.

الرموز ذات الصلة 1
NTES NTES
المصدر: PRNewsWire
زيارة المصدر
تعليق
المصدر: Finbold وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Monster insider trading alert for Microsoft (MSFT) stock

Monster insider trading alert for Microsoft (MSFT) stock

As it turned out, by August 5, Microsoft (NASDAQ: MSFT) stock's late July earnings-driven rally was accompanied by the firm's first insider equity sale in two months and one of the only six in 2026.

الرموز ذات الصلة 1
المصدر: Finbold
زيارة المصدر
تعليق
المصدر: WSJ وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Warby Parker Swings to Profit on Tariff Refund

Warby Parker Swings to Profit on Tariff Refund

Warby Parker swung to a second-quarter profit as results were helped by a tariff refund, offsetting costs of the upcoming launch of its artificial-intelligence eyewear.

الرموز ذات الصلة 1
WRBY WRBY
المصدر: WSJ
زيارة المصدر
تعليق
المصدر: 24/7 Wall Street وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Load Up On AMD Because Its High Beta Will Reward You Now

Load Up On AMD Because Its High Beta Will Reward You Now

At $518.58, Advanced Micro Devices (NASDAQ:AMD | AMD Price Prediction) looks compelling, and its punishing beta of 2.49 works in shareholders' favor at this stage of the AI capex cycle.

الرموز ذات الصلة 1
AMD AMD
المصدر: 24/7 Wall Street
زيارة المصدر
تعليق
المصدر: GlobeNewsWire وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.

argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.

August 6, 2026 – 7:45 AM ET Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology innovation company today announced that Avena Merger Sub Inc. (“Purchaser”), a wholly-owned subsidiary of argenx BV (“argenx”), has commenced a tender offer to purchase all of the issued and outstanding shares of Common Stock, par value $0.001 per share (the “Shares”), of Forte Biosciences, Inc. (“Forte”) (Nasdaq: FBRX), for $77.00 per Share, net to the seller in cash, without interest, subject to any applicable withholding taxes, and upon the terms and subject to the conditions set forth in the Offer to Purchase, dated August 6, 2026, and the accompanying Letter of Transmittal (together, and with other related materials, as they may be amended or supplemented from time to time, the “Offer”). The Offer is being made pursuant to an Agreement and Plan of Merger, dated as of July 26, 2026, by and among Forte, argenx and Purchaser (the “Merger Agreement”).

الرموز ذات الصلة 1
FBRX FBRX
المصدر: GlobeNewsWire
زيارة المصدر
تعليق